Breakthrough lung cancer treatment supercharges immune cells with mitochondria

Researchers have found a way to supercharge immune cells against lung cancer by transplanting healthy mitochondria. When combined with chemotherapy drug cisplatin, this approach doubled drug effectiveness, shrank tumors dramatically, and increased immune cell infiltration while reversing cancer metabolism without additional toxicity. This breakthrough transforms mitochondria from simple energy producers into active cancer-fighting allies, potentially benefiting patients who don't respond to conventional treatments.